Dalian BIO-CHEM Company Limited (603360.SS)
CNY 28.36
(1.29%)
CNY 28.36
(1.29%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 304.98 Million CNY | 4.05% |
| 2022 | 293.12 Million CNY | -52.8% |
| 2021 | 621.06 Million CNY | 40.7% |
| 2020 | 441.41 Million CNY | 183.27% |
| 2019 | 155.82 Million CNY | 56.85% |
| 2018 | 99.34 Million CNY | 6.93% |
| 2017 | 92.9 Million CNY | -44.79% |
| 2016 | 168.27 Million CNY | -10.53% |
| 2015 | 188.07 Million CNY | -28.17% |
| 2014 | 261.83 Million CNY | -2.89% |
| 2013 | 269.63 Million CNY | 1.64% |
| 2012 | 265.27 Million CNY | -3.66% |
| 2011 | 275.35 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 288.55 Million CNY | -13.98% |
| 2024 Q1 | 352.98 Million CNY | 15.74% |
| 2024 Q2 | 335.44 Million CNY | -4.97% |
| 2023 Q1 | 285.98 Million CNY | -2.43% |
| 2023 FY | 304.98 Million CNY | 4.05% |
| 2023 Q2 | 268.88 Million CNY | -5.98% |
| 2023 Q4 | 304.98 Million CNY | 11.91% |
| 2023 Q3 | 272.52 Million CNY | 1.35% |
| 2022 FY | 293.12 Million CNY | -52.8% |
| 2022 Q4 | 293.12 Million CNY | -16.73% |
| 2022 Q3 | 351.99 Million CNY | 2.52% |
| 2022 Q2 | 343.35 Million CNY | -50.45% |
| 2022 Q1 | 692.94 Million CNY | 11.57% |
| 2021 Q2 | 567.37 Million CNY | 8.07% |
| 2021 Q1 | 525.01 Million CNY | 18.94% |
| 2021 FY | 621.06 Million CNY | 40.7% |
| 2021 Q4 | 621.06 Million CNY | 1.14% |
| 2021 Q3 | 614.04 Million CNY | 8.22% |
| 2020 Q4 | 441.41 Million CNY | 14.18% |
| 2020 Q3 | 386.6 Million CNY | -10.68% |
| 2020 FY | 441.41 Million CNY | 183.27% |
| 2020 Q1 | 164.03 Million CNY | 5.27% |
| 2020 Q2 | 432.84 Million CNY | 163.87% |
| 2019 Q3 | 152.32 Million CNY | -10.96% |
| 2019 FY | 155.82 Million CNY | 56.85% |
| 2019 Q4 | 155.82 Million CNY | 2.3% |
| 2019 Q2 | 171.06 Million CNY | 10.32% |
| 2019 Q1 | 155.06 Million CNY | 56.08% |
| 2018 Q2 | 100.33 Million CNY | 13.06% |
| 2018 Q3 | 174.61 Million CNY | 74.02% |
| 2018 Q1 | 88.75 Million CNY | -4.48% |
| 2018 Q4 | 99.34 Million CNY | -43.1% |
| 2018 FY | 99.34 Million CNY | 6.93% |
| 2017 Q1 | 86.71 Million CNY | -48.47% |
| 2017 Q4 | 92.9 Million CNY | 4.93% |
| 2017 Q3 | 88.53 Million CNY | -58.92% |
| 2017 Q2 | 215.53 Million CNY | 148.56% |
| 2017 FY | 92.9 Million CNY | -44.79% |
| 2016 FY | 168.27 Million CNY | -10.53% |
| 2016 Q2 | 170.16 Million CNY | 0.0% |
| 2016 Q4 | 168.27 Million CNY | -0.67% |
| 2016 Q3 | 169.4 Million CNY | -0.44% |
| 2016 Q1 | - CNY | -100.0% |
| 2015 Q4 | 188.07 Million CNY | 0.0% |
| 2015 FY | 188.07 Million CNY | -28.17% |
| 2014 FY | 261.83 Million CNY | -2.89% |
| 2014 Q4 | 261.83 Million CNY | 0.0% |
| 2014 Q1 | 265.48 Million CNY | 0.0% |
| 2014 Q2 | 265.48 Million CNY | 0.0% |
| 2013 FY | 269.63 Million CNY | 1.64% |
| 2012 FY | 265.27 Million CNY | -3.66% |
| 2011 FY | 275.35 Million CNY | 0.0% |